AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szabó, D.
Right arrow Articles by Paterson, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szabó, D.
Right arrow Articles by Paterson, D. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2005, p. 4716-4720, Vol. 49, No. 11
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.11.4716-4720.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Molecular Analysis of the Simultaneous Production of Two SHV-Type Extended-Spectrum Beta-Lactamases in a Clinical Isolate of Enterobacter cloacae by Using Single-Nucleotide Polymorphism Genotyping

Dóra Szabó,1,2 Melissa A. Melan,3 Andrea M. Hujer,4 Robert A. Bonomo,4 Kristine M. Hujer,4 Christopher R. Bethel,4 Katalin Kristóf,1 and David L. Paterson2*

Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary,1 Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213,2 Department of Pathology, Division of Molecular Diagnostics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213,3 Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio 441064

Received 28 March 2005/ Returned for modification 12 June 2005/ Accepted 25 August 2005


    ABSTRACT
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Bacteria that simultaneously produce multiple extended-spectrum beta-lactamases are frequently isolated. We report an Enterobacter cloacae isolate, ES24, producing four different beta-lactamases (AmpC type beta-lactamase, TEM-1, SHV-7, and a novel extended-spectrum beta-lactamase, SHV-30). Direct sequencing of blaSHV gene products gave a "double peak" at position 703, suggesting the presence of more than one allele. Using fluorescence resonance energy transfer real-time PCR to detect single-nucleotide polymorphisms, we were able to distinguish two different blaSHV genes in a single isolate. This may prove to be a useful technique in surveys of beta-lactamase production in contemporary clinical isolates.


    INTRODUCTION
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
It has long been known that extended-spectrum ß-lactamase (ESBL)-producing bacteria cause serious clinical problems (2, 9). ESBL production has become frequent not only in Escherichia coli and Klebsiella pneumoniae but also in other species of Enterobacteriaceae (10). Currently, ESBL-producing organisms frequently produce multiple ß-lactamases (3, 7, 16). This can include the production of ESBLs and non-ESBLs of different types, synthesis of multiple ESBLs of the same type (for example, production of multiple TEM-type ESBLs by the same isolate) (3), or elaboration of chromosomally encoded SHV-1 and an SHV-type ESBL (6).

There are a number of ways in which different ß-lactamase types can be differentiated within a single isolate (8). Analytical isoelectric focusing can provide a clue to the presence and isoelectric points (pIs) of multiple ß-lactamases produced by a single isolate. However, many different ß-lactamases share common isoelectric points, so this method lacks the ability to identify the ß-lactamase type. We have previously performed surveys in which blaSHV, blaTEM, or blaCTX-M genes were amplified, and the primary PCR product was identified by sequencing (16). Such a procedure is easily performed but may not identify multiple ß-lactamases of the same type: genes existing in a lower copy number may be less likely to be detected than those which predominate. The definitive method for detecting multiple ß-lactamases of the same type is extensive cloning and sequencing of the bla genes.

Herein, we report an Enterobacter cloacae isolate which simultaneously produced two different SHV-type ESBLs. We describe a real-time PCR method for detecting single-nucleotide polymorphisms (SNPs) that uses fluorescently labeled oligonucleotide hybridization probes (20). We demonstrate a rapid, sensitive, and specific method that can detect mutations of the blaSHV gene in a single reaction. As a result of this analysis, we identified a novel SHV variant, SHV-30, in a complex ß-lactamase background.


    MATERIALS AND METHODS
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Bacterial isolates. An E. cloacae isolate (designated "ES24") was detected in 2003 in blood cultures from a solid-organ transplant recipient in Pittsburgh. The following isolates were used as controls: K. pneumoniae ATCC 700603 (producing SHV-18) (19), a KPC-1-producing K. pneumoniae isolate (producing SHV-29) (23), E. coli EP-MAX10B, and a well-characterized clinical isolate of E. cloacae producing an AmpC type ß-lactamase. Additionally, well-characterized clinical isolates of E. cloacae producing SHV-5, SHV-7, and SHV-14 were also used (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1. ß-lactamase production of the isolates used in this study

 
Antibiotic susceptibility. The MICs of various antibiotics were determined using Etest strips (AB Biodisk, Solna, Sweden). Susceptibility tests were performed according to the manufacturer's instructions. The following Etest strips were used: aztreonam, cefotaxime, cefotaxime plus clavulanic acid, ceftazidime, ceftazidime plus clavulanic acid, cefepime, cefepime plus clavulanic acid, cefoxitin, and ciprofloxacin. E. coli ATCC 25922 was used as the reference isolate for antimicrobial susceptibility testing. All susceptibility results were interpreted using the breakpoints of the Clinical and Laboratory Standards Institute (formerly NCCLS), current as of 1 January 2005 (15).

Plasmid isolation and transformation. Plasmid DNA from the E. cloacae ES24 isolate was extracted and purified using the protocol and reagents of a commercial kit (Quantum Prep; Bio-Rad, Inc., Hercules, CA) The plasmids were analyzed by electrophoresis on a 0.8% (wt/vol) agarose gel and visualized by ethidium bromide staining under UV light. {lambda} HindIII (Promega, Madison, WI) was used as a molecular weight marker. The plasmid DNA of the E. cloacae ES24 isolate was used to transform electrocompetent E. coli EP-MAX10B (Bio-Rad, Inc.). Transformants were selected on Luria-Bertani agar (Beckton Dickinson, Sparks, MD) containing 0.5 µg/ml cefotaxime (Sigma, St. Louis, MO).

Isoelectric focusing. Analytical isoelectric focusing (IEF) was performed to determine the pIs of ß-lactamases extracted from the E. cloacae ES24 isolate and the plasmid-transformed E. coli EP-MAX10B isolate (17). Electrophoresis was performed on precast polyacrylamide gels, pH 3 to pH 10 (Bio-Rad Inc.). Isoelectric points were determined by placing filter paper soaked in nitrocefin (500 µg/ml; Becton Dickinson) on top of the focused gel (17).

PCR and cloning. A single colony of each test isolate was resuspended in 400 µl water and boiled for 15 min. The resulting supernatant was used as the bacterial DNA template for PCR amplification. The primers are shown in Table 2. Reaction mixtures (30 µl) contained 50 mM KCl, 1.5 mM MgCl2, 0.5 µM of each primer, 1.5 mM of each deoxynucleotide triphosphate (Sigma), 1 U of RedTaq polymerase (Sigma), and 2 µl of the bacterial DNA template. Initially, direct sequencing of the products was performed.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Primers and probes used in this study

 
Next, the amplified blaSHV PCR products were cloned into a pCR-XL-TOPO (TOPO XL PCR cloning kit; Invitrogen, Carlsbad, CA) vector that encodes a kanamycin resistance determinant. The amplified product's nucleotide sequences were determined using the ABI 3700 and ABI 3100 genetic analyzers according to the manufacturer's instructions. Sequence analysis was performed using the Lasergene DNAStar sequencing analysis software (DNAStar, Madison, WI).

Real-time PCR SNP genotyping. To detect the single-nucleotide polymorphisms in blaSHV, we used the 5' nuclease assay developed by Sevall (20). We designed fluorogenic probes consisting of oligonucleotides that possess a reporter dye (6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein [HEX] or 6-carboxyfluorescein [FAM]) and a quencher dye (6-carboxytetramethylrhodamine [TAMRA]) at each end. The probe adopts a hairpin structure while free in solution. The close proximity of the reporter and the quencher in this hairpin suppresses reporter fluorescence (fluorescence resonance transfer [FRET]). During PCR, the dual-labeled probe annealed to the target of interest (blaSHV) between the forward and reverse primer sites. During extension, the probe was cleaved by the 5' nuclease activity of the Taq polymerase. This separated the reporter dye from the quencher dye, generating an increase in the reporter dye's fluorescence intensity (FRET does not occur). Thus, by using two probes containing only a single nucleotide difference combined with two different reporter dyes, single-nucleotide polymorphisms were detected.

Real-time PCR allelic discrimination assays (SNP genotyping) were designed using Primer Express software (Applied Biosystems, Foster City, CA). Primer and probe combinations designed using Primer Express are listed in Table 2. Genotyping was performed in 50-µl reaction mixtures that contained 5 µl of genomic DNA, 900 nM of each primer, 200 nM of each probe, and 25 µl of Taqman Universal PCR Master Mix (contains PCR buffer, passive reference dye ROX [carboxy-X-rhodamine], deoxynucleotides, uridine, uracil-N-glycosylase, and AmpliTaq Gold DNA polymerase; Perkin-Elmer Applied Biosystems). Amplification was performed using an ABI 7000 real-time thermal cycler. Cycling conditions were 2 min at 50°C, 10 min at 95°C, 40 cycles of 95°C for 15 s, and 60°C for 1 min. Real-time fluorescence detection was performed during the 60°C annealing/extension step of each cycle. ABI allelic discrimination software was used to plot and automatically call genotypes based on a two-parameter plot using fluorescence intensities of FAM and HEX at 40 cycles. This software uses autoscaling for the allelic discrimination plot.

Nucleotide sequence accession number. The DNA sequence and deduced amino acid sequence of SHV-30 has been deposited in GenBank and assigned accession number AY661885.


    RESULTS
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Phenotypic characterization of E. cloacae ES24. We isolated six plasmids from the E. cloacae ES24 isolate. The plasmids had the following estimated sizes: 9.4, 3.0, 2.5, 2.3, 2.0, and ~0.8 kb. In an attempt to isolate plasmids harboring genes encoding ß-lactamases, transformation experiments were performed. It was only possible to transform the largest plasmid (9.4 kb) into E. coli EP-MAX10B. The antibiotic susceptibilities of both the E. cloacae ES24 and the plasmid-transformed E. coli EP-MAX10B isolates are shown in Table 3. ES24 was resistant to ceftazidime, aztreonam, and cefoxitin but was intermediate to cefotaxime and cefepime. The cefepime MIC decreased in the presence of clavulanic acid. The MICs of the plasmid-transformed E. coli EP-MAX10B isolate were much lower than those of E. cloacae ES24 (Table 3), with MICs for all tested antibiotics being in the susceptible range.


View this table:
[in this window]
[in a new window]
 
TABLE 3. MIC values of the E. cloacae ES24 isolate and the plasmid-transformed E. coli EP-MAX10B by Etest

 
In order to characterize the ß-lactamases from E. cloacae ES24 and the plasmid-transformed E. coli EP-MAX10B isolate, isoelectric focusing was performed. Four different ß-lactamases with pI values of 5.4, 6.7, 7.6, and ≥9 were identified in the E. cloacae ES24 isolate. The plasmid-transformed E. coli EP-MAX10B isolate produced only one ß-lactamase (with a pI value of 6.7) (Fig. 1).



View larger version (53K):
[in this window]
[in a new window]
 
FIG. 1. Isoelectric focusing of strain ES24 and the SHV-30-producing, plasmid-transformed E. coli EP-MAX10B isolate. Lane 1, IEF standard; lane 2, strain ES24; lane 3, the SHV-30-producing, plasmid-transformed E. coli EP-MAX10B isolate.

 
PCR amplification and sequencing analysis. PCR amplification of bla genes in E. cloacae ES24 identified both blaTEM and blaSHV. The blaTEM was identified as blaTEM-1. Sequence analysis of the blaSHV PCR product revealed three nucleotide substitutions in the E. cloacae ES24 isolate that resulted in three amino acid changes. At Ambler position 8, Ile changed to Phe; at position 43, Arg changed to Ser; and at position 238, Gly changed to Ser. Further sequence analysis in E. cloacae ES24 revealed two different codons at Ambler position 240, GAA (Glu) and AAA (Lys), i.e., two peaks were seen (Fig. 2).



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 2. The sequencing result of the ES24 isolate from position 692 to position 711. N indicates two different peaks (G and A).

 
In order to confirm that the E. cloacae ES24 isolate was producing different SHV-enzymes, the blaSHV PCR product of E. cloacae ES24 isolate was cloned into the TOPO vector. The cloned isolates carried either the blaSHV-7 gene (position 8, Ile to Phe; position 43, Arg to Ser; position 238, Gly to Ser; and position 240, Glu to Lys) or the novel blaSHV-30 gene (position 8, Ile to Phe; position 43, Arg to Ser; and position 238, Gly to Ser) (12).

The plasmid-transformed E. coli EP-MAX10B isolate was found to be negative for blaTEM by PCR amplification, but it was found to be positive for blaSHV. The sequence analysis showed that the plasmid-transformed E. coli EP-MAX10B isolate carried only the novel blaSHV-30 gene. This finding was further confirmed by IEF (Fig. 1).

Real-time PCR SNP genotyping. Real-time PCR SNP was performed on the E. cloacae ES24 isolate (SHV-7 and SHV-30) and plasmid-transformed E. coli EP-MAX10B (SHV-30) as well as the following control isolates: K. pneumoniae ATCC 700603 (SHV-18), KPC-1-producing K. pneumoniae isolate (SHV-29), an E. coli EP-MAX10B isolate, AmpC ß-lactamase-producing clinical E. cloacae isolate, and ESBL (SHV-5, SHV-7, and SHV-14)-producing and AmpC ß-lactamase-producing clinical E. cloacae isolates (Table 1).

In our study, probes were designed to identify mutations affecting amino acid position 240 alleles GAA (Glu) and AAA (Lys) (1). Table 4 lists the results of the isolates tested and a comparison of their nucleotide sequences at the positions of probes. If the probes hybridized, the increase in fluorescence signal of one dye over the other indicated homozygosity for that PCR allele (FAM fluorescence for the G allele, and HEX fluorescence for the A allele). An increase in both signals indicated heterozygosity. The amplification fluorescence intensities are compared in a graphical form (Fig. 3). Clusters of points on the graph correspond to the homozygous G genotype, the homozygous A genotype, the heterozygous GA genotype, or to a genotype with no amplification.


View this table:
[in this window]
[in a new window]
 
TABLE 4. Comparison of the nucleotide sequence (692 to 711) of the SHV positive isolates and the allelic discrimination result

 


View larger version (15K):
[in this window]
[in a new window]
 
FIG. 3. Allelic discrimination. {blacklozenge}, SHV-30-producing, plasmid-transformed E. coli EP-MAX10B isolate and SHV-14-producing E. cloacae isolate; {blacktriangleup}, E. cloacae ES24; •, two SHV-5-producing and five SHV-7 producing E. cloacae isolates; -, SHV-18-producing K. pneumoniae ATCC 700603, SHV-29-producing KPC-1 isolate, E. coli EP-MAX10B, and chromosomal AmpC ß-lactamase-producing E. cloacae isolate; {blacksquare}, water.

 
The E. cloacae ES24 isolate showed substantial increases in both FAM and HEX dye fluorescence (Fig. 3). An increase in both signals indicates heterozygosity for G and A alleles at nucleotide position 703.

The plasmid-transformed E. coli EP-MAX10B (SHV-30- producing) isolate and the SHV-14-producing clinical E. cloacae isolates showed increased FAM fluorescence and unchanged HEX fluorescence, indicating homozygosity for the FAM-specific G allele. Only the G at the 703 nucleotide position was present (Fig. 3). However, the SHV-14-producing E. cloacae isolate contained one nucleotide difference at position 700 relative to the probe (Table 4).

The two SHV-5-producing and the five SHV-7-producing clinical E. cloacae isolates showed increases in only HEX dye fluorescence, indicating the specific A allele at nucleotide position 703 (Fig. 3).

The SHV-18-producing K. pneumoniae ATCC 700603 isolate and the SHV-29-producing KPC-1 isolate showed no change in the fluorescence intensity for either FAM or HEX (Fig. 3). Based on their sequencing results, the SHV-18-producing K. pneumoniae ATCC 700603 isolate had an A nucleotide at position 703, and the SHV-29-producing KPC-1 isolate had a G nucleotide at position 703; despite this, there was no increase in fluorescence signal for the HEX-specific A allele and the FAM-specific G allele. The reason is that both isolates have two differences at nucleotide positions 700 and 701 relative to the probes (Table 4), resulting in a lack of binding of the specific probe.

The nontransformed E. coli EP-MAX10B isolate and the chromosomal AmpC ß-lactamase-producing E. cloacae isolate also showed no change in fluorescence intensity for either FAM or HEX (Fig. 3) because they did not contain the blaSHV gene.


    DISCUSSION
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Enterobacter spp. produce a chromosomally encoded AmpC ß-lactamase. Enterobacter isolates have also been reported to produce ESBLs of TEM and SHV types. Of these, SHV-7 has been recently reported from E. cloacae isolates in Philadelphia (11). SHV-7 ß-lactamase was first identified in an E. coli isolate in 1995 in New York (4) and has also been produced in K. pneumoniae isolates (21).

Our E. cloacae ES24 isolate produced AmpC, TEM-1, and SHV-7 ß-lactamases and a novel ß-lactamase, SHV-30, with a pI of 6.7. This is the first isolation of SHV-30 from an Enterobacter isolate and the first report of an E. cloacae isolate producing two different SHV enzymes. The amino acid sequence of SHV-30 differed from the amino acid sequence of SHV-1 by three amino acid substitutions: isoleucine for phenylalanine at position 8, arginine for serine at position 43, and glycine for serine at position 238. An investigation of the effect of these mutations on the active site of the enzyme and on antibiotic hydrolysis is under further investigation.

Methods that can be used to rapidly and reliably characterize ß-lactamases and the genes that encode them are still being sought. To identify two different blaSHV genes within a single bacterial isolate is not simple. To assist with this, a combination of isoelectric focusing and restriction fragment length polymorphism (RFLP) analysis of SHV-specific PCR products has been developed (8). As noted previously, determination of the pI of the enzyme is insufficient to identify SHV-derived ß-lactamases due to the frequent similarity of pI values. The PCR-RFLP technique is a simple and rapid alternative, but it cannot identify all known mutations, such as those affecting amino acids at positions 8, 238, or 240. PCR single-strand conformational polymorphism analysis was developed to characterize ß-lactamases in the SHV family (13). PCR single-strand conformational polymorphism analysis has also been used to differentiate two different blaSHV gene types within a single bacterial isolate (14, 24). Restriction site insertion-PCR has been used to detect mutations of blaSHV genes that cannot be identified by PCR-RFLP. This technique uses primers with one to three base mismatches near the 3' end which modulate target restriction sites (5). All of these techniques, however, rely on the high specificity of restriction endonucleases to identify the restriction sites.

Real-time PCR and melting-curve analysis have been previously used for rapid detection of the blaSHV ESBLs (18). We have used a rapid method based on FRET real-time PCR to identify two different blaSHV genes in a single E. cloacae isolate. Real-time allelic discrimination is a fluorescence detection system that collects fluorescence measurements during the amplification. The DNA assay with amplification and detection in a single step allows the analysis of the amplification product without extensive postamplification processing. A mismatch between probe and target greatly reduces the efficiency of probe hybridization and its subsequent hydrolysis. In our case, if there were two additional nucleotide mismatches, the probes were unable to hybridize.

With this method, probes also can be designed to identify every target, even those that do not generate unique restriction endonuclease sites. With this method, more than two alleles could potentially be distinguished. The further advantage of this method is that it could be used for genes encoding other types of ß-lactamases, such as blaCTX-M or blaTEM.

In summary, the real-time PCR SNP assay proved useful in a situation where amplification from genome extracts, with sequencing of the primary PCR product, suggested that two ß-lactamases were present. We found the technique to be highly reproducible, and it could be performed without postamplification steps. The present assay was designed to conform to standard thermocycling conditions, thus allowing several SNPs to be identified simultaneously. This approach may be extremely useful when applied to large population survey studies that attempt to define the molecular epidemiology of ß-lactamase genes.


    ACKNOWLEDGMENTS
 
We thank Kathleen Deeley for her technical assistance.

We are grateful to Fred Tenover for providing the K. pneumoniae isolate which produced KPC-1.

R.A.B. was supported by the Department of Veterans Affairs Merit Review Program and NIH grant R01AI063517-01.


    FOOTNOTES
 
* Corresponding author. Mailing address: Division of Infectious Diseases, University of Pittsburgh Medical Center, Suite 3A Falk Medical Building, 3601 5th Avenue, Pittsburgh, PA 15213. Phone: (412) 648-6478. Fax: (412) 648-6399. E-mail: patersond{at}dom.pitt.edu. Back


    REFERENCES
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ambler, R. P., A. F. Coulson, J. M. Frere, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A beta-lactamases. Biochem. J. 276:269-270.
  2. Bradford, P. A. 2001. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.[Abstract/Free Full Text]
  3. Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrob. Agents Chemother. 38:761-766.[Abstract/Free Full Text]
  4. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.[Abstract]
  5. Chanawong, A., F. H. M'Zali, J. Heritage, A. Lulitanond, and P. M. Hawkey. 2001. Discrimination of SHV beta-lactamase genes by restriction site insertion-PCR. Antimicrob. Agents Chemother. 45:2110-2114.[Abstract/Free Full Text]
  6. Chang, F. Y., L. K. Siu, C. P. Fung, M. H. Huang, and M. Ho. 2001. Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26. Antimicrob. Agents Chemother. 45:2407-2413.[Abstract/Free Full Text]
  7. Essack, S. Y., L. M. Hall, D. G. Pillay, M. L. McFadyen, and D. M. Livermore. 2001. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob. Agents Chemother. 45:88-95.[Abstract/Free Full Text]
  8. Hanson, N. D., K. S. Thomson, E. S. Moland, C. C. Sanders, G. Berthold, and R. G. Penn. 1999. Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J. Antimicrob. Chemother. 44:377-380.[Abstract/Free Full Text]
  9. Jacoby, G. A. 1997. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams. Infect. Dis. Clin. N. Am. 11:875-887.[CrossRef][Medline]
  10. Jacoby, G. A., and L. S. Munoz-Price. 2005. The new beta-lactamases. N. Engl. J. Med. 352:380-391.[Free Full Text]
  11. Levison, M. E., Y. V. Mailapur, S. K. Pradhan, G. A. Jacoby, P. Adams, C. L. Emery, P. L. May, and P. G. Pitsakis. 2002. Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia teaching hospitals. Clin. Infect. Dis. 35:1551-1554.[CrossRef][Medline]
  12. Mulvey, M. R., E. Bryce, D. Boyd, M. Ofner-Agostini, S. Christianson, A. E. Simor, and S. Paton. 2004. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48:1204-1214.[Abstract/Free Full Text]
  13. M'Zali, F. H., D. M. Gascoyne-Binzi, J. Heritage, and P. M. Hawkey. 1996. Detection of mutations conferring extended-spectrum activity on SHV beta-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP). J. Antimicrob. Chemother. 37:797-802.[Abstract/Free Full Text]
  14. M'Zali, F. H., J. Heritage, D. M. Gascoyne-Binzi, A. M. Snelling, and P. M. Hawkey. 1998. PCR single strand conformational polymorphism can be used to detect the gene encoding SHV-7 extended-spectrum beta-lactamase and to identify different SHV genes within the same strain. J. Antimicrob. Chemother. 41:123-125.[Abstract/Free Full Text]
  15. NCCLS. 2005. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  16. Paterson, D. L., K. M. Hujer, A. M. Hujer, B. Yeiser, M. D. Bonomo, L. B. Rice, and R. A. Bonomo. 2003. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.[Abstract/Free Full Text]
  17. Paterson, D. L., L. B. Rice, and R. A. Bonomo. 2001. Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniae. Clin. Microbiol. Infect. 7:709-711.[CrossRef][Medline]
  18. Randegger, C. C., and H. Hachler. 2001. Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 45:1730-1736.[Abstract/Free Full Text]
  19. Rasheed, J. K., G. J. Anderson, H. Yigit, A. M. Queenan, A. Domenech-Sanchez, J. M. Swenson, J. W. Biddle, M. J. Ferraro, G. A. Jacoby, and F. C. Tenover. 2000. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob. Agents Chemother. 44:2382-2388.[Abstract/Free Full Text]
  20. Sevall, J. S. 2001. Rapid allelic discrimination from real-time DNA amplification. Methods 25:452-455.[CrossRef][Medline]
  21. Wang, M., D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2004. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48:1295-1299.[Abstract/Free Full Text]
  22. Yagi, T., H. Kurokawa, N. Shibata, K. Shibayama, and Y. Arakawa. 2000. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett. 184:53-56.[Medline]
  23. Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.[Abstract/Free Full Text]
  24. Yuan, M., H. Aucken, L. M. Hall, T. L. Pitt, and D. M. Livermore. 1998. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J. Antimicrob. Chemother. 41:527-539.[Abstract/Free Full Text]


Antimicrobial Agents and Chemotherapy, November 2005, p. 4716-4720, Vol. 49, No. 11
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.11.4716-4720.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szabó, D.
Right arrow Articles by Paterson, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szabó, D.
Right arrow Articles by Paterson, D. L.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS